MPM BioVentures 2014, L.P.

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$25.13M
Insider Sells Quantity
45
Insider Sells Sum
$30.83M

Insider Activity of MPM BioVentures 2014, L.P.

According to the SEC Form 4 filings, MPM BioVentures 2014, L.P., being in a position of

  1. 10 percent owner at Entrada Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 44722 shares for $917,111,
    over all time since 2021-11-02, has bought 200000 shares for $4M, and sold 44722 shares for $917,111.

The largest purchase of all time was on 2020-06-23 and amounted to 500000 shares of Repare Therapeutics Inc. for $10M.

The largest sale of all time was on 2022-01-04 and amounted to 128550 shares of iTeos Therapeutics, Inc. for $5.48M.

Biography of MPM BioVentures 2014, L.P.

No biography is available at this moment.

2024-12-11SaleEntrada Therapeutics, Inc.
TRDA
10 percent owner
21,787
0.0592%
$20.23$440,751-10.38%
2024-12-10SaleEntrada Therapeutics, Inc.
TRDA
10 percent owner
22,935
0.0623%
$20.77$476,360-12.19%
2022-01-05SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
18,135
0.0512%
$42.03$762,214-46.62%
2022-01-04SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
128,550
0.3679%
$42.66$5.48M-46.05%
2021-12-07SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
19,456
0.0556%
$33.22$646,401-26.45%
2021-12-06SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
10,208
0.0294%
$32.59$332,698-23.88%
2021-12-03SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
20,167
0.0572%
$34.79$701,513-29.41%
2021-12-02SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
37,187
0.1023%
$33.96$1.26M-29.48%
2021-12-01SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
12,395
0.0363%
$34.28$424,872-25.06%
2021-11-30SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
33,937
0.0959%
$35.09$1.19M-29.02%
2021-11-29SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
10,371
0.0295%
$34.49$357,656-26.83%
2021-11-26SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
12,674
0.0366%
$35.75$453,110-28.03%
2021-11-24SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
36,337
0.1013%
$36.29$1.32M-31.42%
2021-11-23SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
20,004
0.0565%
$36.22$724,449-30.33%
2021-11-22SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
21,114
0.0612%
$37.52$792,271-30.94%
2021-11-02PurchaseEntrada Therapeutics, Inc.
TRDA
10 percent owner
200,000
2.5047%
$20.00$4M-53.61%
2021-10-18SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
6,167
0.0172%
$27.14$167,372+0.6%
2021-10-15SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
10,932
0.0307%
$27.62$301,937-0.36%
2021-10-14SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
27,320
0.0773%
$27.30$745,836+1.68%
2021-10-13SaleiTeos Therapeutics, Inc.
ITOS
10 percent owner
20,929
0.061%
$27.13$567,804+5.41%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.